Ichnos Glenmark Innovation Email Format

Biotechnology ResearchUnited States51-200 Employees

IGI, Inc. is a global, fully integrated clinical-stage biotechnology company focused on developing innovative biologics in oncology. 

Headquartered in New York, NY, IGI is advancing a robust pipeline of novel, first-in-class Multispecifics™ aimed at addressing complex diseases and treating patients holistically. Powered by its proprietary BEAT® technology platform, IGI is committed to delivering breakthrough, curative therapies to improve and extend the lives of patients battling hematological malignancies and solid tumors.

Sign up for free to view info

Company overview Employee directory